Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Eli Lilly Whomps Novo Nordisk
Eli Lilly's GLP-1 outdoes Novo Nordisk's in trial
Adults taking Eli Lilly's Zepbound lost 47% more weight on average than those on Novo Nordisk's Wegovy, Lilly reported from the first head-to-head trial comparing the two blockbuster GLP-1 obesity drugs.
Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight-Loss Trial
Eli Lilly's popular weight-loss drug Zepbound outperformed Danish drugmaker Novo Nordisk's Wegovy in a clinical trial, according results of the study released Wednesday.
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in a study.
3h
on MSN
Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments
Eli
Lilly
said it would invest $3 billion to expand a recently ... Zepbound and Mounjaro.
Lilly
’s rival,
Novo
...
1d
on MSN
Eli Lilly Just Got a Bundle of Good News: Time to Buy?
One of Eli Lilly's potential competitors in the weight loss market just reported unimpressive trial results. The company ...
2d
Exclusive: Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Tsunami warnings lifted
French government falls
Fox News commentator dies
Images of suspect released
Set to return after 20 years
Congress halts Ukraine aid
May cut diabetes risk
Recuses himself from case
Nadler to step aside
Ethics report release blocked
Delays oil output hike
Winter storm to hit US
Taiwan's pres visits Guam
Satellites to create eclipses
Theriault ends recount
MX record fentanyl bust
DOJ: Bias against Blacks
Social Security chief pick
Independent run for gov.
Leaded gas health risk
Medellin cartel leader freed
US telecom firms hacked
Rockefeller tree lights up
Tops $100K for the first time
Composer Laird dies at 85
Raw milk recall expands
$10B AI data center in LA
Billy Long to lead IRS
Recalls over 205,000 SUVs
Weekly jobless claims rise
US trade deficit shrinks
Airlines to pay for delays?
Prenatal test spots cancer?
SpaceX sets record
Syrian rebels capture Hama
Airbus layoffs
Feedback